Filing Details

Accession Number:
0001437749-15-004220
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-05 17:44:10
Reporting Period:
2015-03-03
Filing Date:
2015-03-05
Accepted Time:
2015-03-05 17:44:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389545 Novabay Pharmaceuticals Inc. NBY Pharmaceutical Preparations (2834) 680454536
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1410081 Ramin Najafi C/O Novabay Pharmaceuticals, Inc.
5980 Horton Street, Suite 550
Emeryville CA 94608
Chief Executive Officer Yes Yes Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-03 166,666 $0.60 3,391,666 No 4 P Indirect Ownership through the Najafi Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Ownership through the Najafi Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2015-03-03 166,666 $0.60 166,666 $0.60
Common Stock Warrant Acquisiton 2015-03-03 124,999 $0.65 124,999 $0.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
291,665 2015-09-06 2016-06-06 No 4 P Indirect
291,665 2015-06-06 2020-06-06 No 4 P Indirect
Footnotes
  1. Warrant to purchase common stock